Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06975306 · ClinicalTrials.gov registry record · NA
Radiographic Findings and Clinical Outcomes After Bone Grafting Patellar Defect in ACL Reconstruction
A NA study of ACL Injuries and Bone Graft; Complications, sponsored by University of Arizona.
- Recruiting
- Registry status
- NA
- Development phase
- 75
- Enrollment target
- 3
- Study locations
NCT06975306: Recruiting NA study of ACL Injuries and Bone Graft; Complications, sponsored by University of Arizona.
NCT06975306 is a NA study of ACL Injuries and Bone Graft; Complications that is actively recruiting participants, run by University of Arizona. The registered enrollment target is 75 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). The trial reports 3 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06975306, a NA study of ACL Injuries and Bone Graft; Complications, is actively recruiting participants, sponsored by University of Arizona.
- RECRUITING
- Registry status
- NA
- Development phase
- 75 participants
- Enrollment target
- 3
- Study locations
Study Summary
All patients will be randomly assigned using a computer randomization algorithm to one of two matched cohort groups. Patients will not be advised which group they belong to until after the completion of the study. One group will be treated with autologous bone graft for bone patellar-tendon bone (BTB) Anterior Cruciate Ligament Reconstruction (ACLR), and the other group will be treated with commercially available DBM (Demineralized bone matrix) putty. Patients will be enrolled from Banner University. Before and after surgery, patient reported outcomes including visual analog pain scale (VAS), Tegner-Lysholm and Cincinnati ACL Test. The principal investigator will evaluate the patients on subjective criteria such as pain and objective criteria including range of motion, arthritic changes seen on radiographs, infection, and ability to kneel.
Conditions Studied
Interventions
- PROCEDURE autologous bone grafts
- OTHER Demineralized bone matrix (DBM)
Study Locations (3)
Arizona
- Banner University Medical Center Phoenix - Phoenix
- Banner Health Center Plus - Arcadia - Phoenix
- Banner Sports Medicine Scottsdale - Scottsdale
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2025-02-11 |
| Est. Completion | 2026-05-31 |
| Phase | NA |
What NCT06975306 shows while recruiting
NCT06975306 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 75 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 2 conditions, with ACL Injuries appearing as the primary indexed condition, and to 2 interventions - of which autologous bone grafts is the first listed.
NCT06975306 reports a single indexed study location in Arizona.
Frequently Asked Questions
What is clinical trial NCT06975306 about?
NCT06975306 is a clinical study titled "Radiographic Findings and Clinical Outcomes After Bone Grafting Patellar Defect in ACL Reconstruction". All patients will be randomly assigned using a computer randomization algorithm to one of two matched cohort groups. Patients will not be advised which group they belong to until after the completion of the study. One group will be treated with autologous bone graft for bone patellar-tendon bone (BT...
What is the current status of trial NCT06975306?
This trial is currently recruiting. It is a NA study. The enrollment target is 75 participants. The study started on 2025-02-11. Estimated completion is 2026-05-31.
What conditions does trial NCT06975306 study?
This clinical trial studies the following conditions: ACL Injuries, Bone Graft; Complications.
What interventions are being tested in trial NCT06975306?
The interventions under investigation include: autologous bone grafts (PROCEDURE), Demineralized bone matrix (DBM) (OTHER).
Who is sponsoring clinical trial NCT06975306?
This trial is sponsored by University of Arizona, which has 349 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06975306 being conducted?
This trial has 3 study locations across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for ACL Injuries
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06975306's enrollment target sits among peer trials
75 1069th of 2000 higher than 919 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01535430 · 75 participants
Assessment of Eloquent Function in Brain Tumor Patients
- NCT01542879 · 75 participants · Phase 1
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
- NCT02232191 · 75 participants · Phase 2
Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients
- NCT02754544 · 75 participants · NA
Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI